
El En SpA
MIL:ELN

El En SpA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.62
12.38
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does El En SpA hold over its rivals?
What risks and challenges
does El En SpA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of El En SpA.
Provide an overview of the primary business activities
of El En SpA.
What unique competitive advantages
does El En SpA hold over its rivals?
What risks and challenges
does El En SpA face in the near future?
Summarize the latest earnings call
of El En SpA.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for El En SpA.
Provide P/S
for El En SpA.
Provide P/E
for El En SpA.
Provide P/OCF
for El En SpA.
Provide P/FCFE
for El En SpA.
Provide P/B
for El En SpA.
Provide EV/S
for El En SpA.
Provide EV/GP
for El En SpA.
Provide EV/EBITDA
for El En SpA.
Provide EV/EBIT
for El En SpA.
Provide EV/OCF
for El En SpA.
Provide EV/FCFF
for El En SpA.
Provide EV/IC
for El En SpA.
Show me price targets
for El En SpA made by professional analysts.
What are the Revenue projections
for El En SpA?
How accurate were the past Revenue estimates
for El En SpA?
What are the Net Income projections
for El En SpA?
How accurate were the past Net Income estimates
for El En SpA?
What are the EPS projections
for El En SpA?
How accurate were the past EPS estimates
for El En SpA?
What are the EBIT projections
for El En SpA?
How accurate were the past EBIT estimates
for El En SpA?
Compare the revenue forecasts
for El En SpA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of El En SpA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of El En SpA against its competitors.
Analyze the profit margins
(gross, operating, and net) of El En SpA compared to its peers.
Compare the P/E ratios
of El En SpA against its peers.
Discuss the investment returns and shareholder value creation
comparing El En SpA with its peers.
Analyze the financial leverage
of El En SpA compared to its main competitors.
Show all profitability ratios
for El En SpA.
Provide ROE
for El En SpA.
Provide ROA
for El En SpA.
Provide ROIC
for El En SpA.
Provide ROCE
for El En SpA.
Provide Gross Margin
for El En SpA.
Provide Operating Margin
for El En SpA.
Provide Net Margin
for El En SpA.
Provide FCF Margin
for El En SpA.
Show all solvency ratios
for El En SpA.
Provide D/E Ratio
for El En SpA.
Provide D/A Ratio
for El En SpA.
Provide Interest Coverage Ratio
for El En SpA.
Provide Altman Z-Score Ratio
for El En SpA.
Provide Quick Ratio
for El En SpA.
Provide Current Ratio
for El En SpA.
Provide Cash Ratio
for El En SpA.
What is the historical Revenue growth
over the last 5 years for El En SpA?
What is the historical Net Income growth
over the last 5 years for El En SpA?
What is the current Free Cash Flow
of El En SpA?
Discuss the annual earnings per share (EPS)
trend over the past five years for El En SpA.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
IT |
![]() |
El En SpA
MIL:ELN
|
731.5m EUR | 1.1 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
228.5B USD | 5.4 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
180.6B USD | 21.6 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
147.4B USD | 8.8 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
144B USD | 6.4 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
114B USD | 3.4 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
65.7B USD | 3.2 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
53.9B EUR | 2.4 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
42.4B USD | 7.8 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
273.8B CNY | 7.4 |
|
US |
![]() |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.3B USD | 1.8 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
IT |
![]() |
El En SpA
MIL:ELN
|
Average P/S:
6.3
1.1
|
4%
|
0.3 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
5.4
|
7%
|
0.8 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
21.6
|
16%
|
1.4 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
8.8
|
12%
|
0.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
6.4
|
9%
|
0.7 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
3.4
|
5%
|
0.7 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
3.2
|
6%
|
0.5 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
2.4
|
7%
|
0.3 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
7.8
|
10%
|
0.8 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
7.4
|
14%
|
0.5 |
|
US |
![]() |
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
1.8
|
4%
|
0.5 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.